Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages - Wikidata - wikimedia - TriplyDB

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages

http://www.wikidata.org/entity/Q35579056

about

Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation.Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran.Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations Colorectal cancer carcinogenesis: a review of mechanisms Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer.Investigation of FIH-1 and SOCS3 expression in KRAS mutant and wild-type patients with colorectal cancer.Association between clinicopathological characteristics and RAS mutation in colorectal cancer.KRAS Alleles: The Devil Is in the Detail.Mutations of key driver genes in colorectal cancer progression and metastasis.Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer.Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and Tumors.Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells.Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog

P2860

Q30238915-FC9E5B36-4461-432A-ADD7-7B4FF7315029 Q33739940-A5AE9C93-96F2-4F1D-A6E6-241641A16390 Q36229011-6A676268-6105-4DDF-82B7-2DCD9550CB57 Q36545430-7EEE3089-7084-4BD6-9B2C-1D166230BD60 Q36849645-7C6DDE8C-74F0-46E8-827D-21C6F73DBD68 Q39139086-668AA251-ED6A-4165-BBE6-4E4439509E85 Q40125078-0ED4B9FD-4154-4087-B86E-84D453D9032D Q48010330-3ACFFA6C-1E40-406A-B503-C1B850641DE4 Q49668169-25931C54-6886-4410-ABB2-1678F2BE07E1 Q50097873-CBA7BBDF-C4BB-42EA-9C03-013842B84AF2 Q52641338-6EB5083A-BC70-47BA-A5AE-BD30D0DF4C3C Q55121561-E0F901B6-B813-4085-B466-E35AF10E09FE Q55220652-7604494A-871E-4D04-920E-731E57FB6D53 Q57163660-FCBE355B-3155-49D8-B50B-6FDD8506E01B

P2860

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages

http://www.wikidata.org/entity/Q35579056

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Colorectal carcinomas with KRA ...... ith more advanced tumor stages

@ast

Colorectal carcinomas with KRA ...... ith more advanced tumor stages

@en

type

label

Colorectal carcinomas with KRA ...... ith more advanced tumor stages

@ast

Colorectal carcinomas with KRA ...... ith more advanced tumor stages

@en

prefLabel

Colorectal carcinomas with KRA ...... ith more advanced tumor stages

@ast

Colorectal carcinomas with KRA ...... ith more advanced tumor stages

@en

P1433

Q35579056-3651F648-AF6D-4414-BC9A-A1E796B18F28

P1476

Q35579056-E8C90AC8-29A0-4EA1-AEB3-52CC2BAEC34F

P2093

Q35579056-06013072-E9DB-4DD0-9B83-DA4FB04DF5E8

Q35579056-16977863-0286-4A45-860F-3030DEFCA247

Q35579056-3C231AA4-FC49-4128-A4C6-3E2302879A2E

Q35579056-4EA76029-8C88-43F1-BF4C-18D4860ED6FF

Q35579056-6E3FB230-29FF-4B5A-9DC2-24A77857456E

Q35579056-866A9946-4C2F-4F4A-A079-DC4A38A578BC

Q35579056-A0F75185-CF60-4285-B587-2C08D0A533D6

Q35579056-BD399CE8-AE69-48FA-A121-5B253490CC97

Q35579056-D6FB82B2-8F0D-475A-A69A-06C7F5FC1B46

P2860

Q35579056-07FE73A8-4BD9-486C-B5E1-59526F268972

Q35579056-0B5CC330-A49B-45A7-A36E-4A768A4C3D46

Q35579056-16AF687F-7DD6-4353-81A0-56FBF4E1658D

Q35579056-1E758D11-D308-4A16-8A43-B7BC8A31DEEE

Q35579056-20F18521-80A9-4041-B2BC-BEEFF251E837

Q35579056-234CD855-BCD1-4BF8-83B8-64A1E0360A20

Q35579056-26936449-8902-4B62-BA6F-51183A66389C

Q35579056-2C64D0F6-A8C8-47AB-A751-68BBE6FD902B

Q35579056-2FA716B2-2469-4E1F-95C8-EAAB239666D8

Q35579056-36D6B436-423D-4AA2-B9BC-FF6BB7BEDA33

P2888

Q35579056-93BEEA10-8492-4FD4-8A95-9F66CCCBB4C1

P304

Q35579056-FC5F6F2F-98AF-4F1A-8B07-E68F76DF4144

P31

Q35579056-8CA4855A-1C75-4A01-BD1F-943F741E03DB

P356

Q35579056-9A5C2754-2787-4228-88D8-F38C9C3A8144

P407

Q35579056-64C4504F-34A1-49F5-8AA6-71F0899DFEEF

P478

Q35579056-87E6B9CA-05FB-4BF9-AD09-F95E8170A52A

P577

Q35579056-3EBAECA2-AD7D-4651-9A71-1CB82F7712C9

P5875

Q35579056-866AC437-3BC0-4843-9804-FBF6190F42BF

P6179

Q35579056-B09271B7-C415-482C-8456-65F1B4F845A6

P698

Q35579056-F82DA117-C1E7-4927-80D4-AAAAB1AA7670

P921

Q35579056-e5421a7e-4e7e-cbd9-071d-286ea6ec2352

P932

Q35579056-106D7635-43D6-4B99-ADBD-6C21EB6D6298

P356

S12885-015-1345-3

P1433

P1476

Colorectal carcinomas with KRA ...... ith more advanced tumor stages

@en

P2093

Jianming Ying

http://www.w3.org/2001/XMLSchema#string

Ling Shan

http://www.w3.org/2001/XMLSchema#string

Ning Lu

http://www.w3.org/2001/XMLSchema#string

Shuangmei Zou

http://www.w3.org/2001/XMLSchema#string

Susheng Shi

http://www.w3.org/2001/XMLSchema#string

Tian Qiu

http://www.w3.org/2001/XMLSchema#string

Wenbin Li

http://www.w3.org/2001/XMLSchema#string

Wenxue Zhi

http://www.w3.org/2001/XMLSchema#string

Yun Ling

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

Microsatellite instability in colorectal cancer

Comprehensive molecular characterization of human colon and rectal cancer

Cetuximab for the treatment of colorectal cancer.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.

Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Systematic review of microsatellite instability and colorectal cancer prognosis

P2888

s12885-015-1345-3

P304

340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1345-3

http://www.w3.org/2001/XMLSchema#string

P407

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275665919

http://www.w3.org/2001/XMLSchema#string

P6179

1001107948

http://www.w3.org/2001/XMLSchema#string

P698

25929517

http://www.w3.org/2001/XMLSchema#string

P921

colorectal carcinoma

P932

4423107

http://www.w3.org/2001/XMLSchema#string